Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |